AROLDI, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 1.385
EU - Europa 958
AS - Asia 421
SA - Sud America 27
AF - Africa 8
OC - Oceania 1
Totale 2.800
Nazione #
US - Stati Uniti d'America 1.375
IT - Italia 414
SG - Singapore 179
DE - Germania 160
IE - Irlanda 132
CN - Cina 94
SE - Svezia 82
RU - Federazione Russa 65
HK - Hong Kong 58
ID - Indonesia 29
GB - Regno Unito 23
FI - Finlandia 22
BR - Brasile 19
IN - India 16
TR - Turchia 13
VN - Vietnam 12
FR - Francia 10
CA - Canada 9
NL - Olanda 8
PT - Portogallo 8
EG - Egitto 6
IR - Iran 6
CO - Colombia 5
CZ - Repubblica Ceca 5
PL - Polonia 5
ES - Italia 4
NO - Norvegia 4
UA - Ucraina 4
AR - Argentina 3
AT - Austria 3
BG - Bulgaria 3
AZ - Azerbaigian 2
LA - Repubblica Popolare Democratica del Laos 2
LT - Lituania 2
PH - Filippine 2
RS - Serbia 2
AM - Armenia 1
AU - Australia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
IQ - Iraq 1
JO - Giordania 1
JP - Giappone 1
KG - Kirghizistan 1
KR - Corea 1
MA - Marocco 1
PK - Pakistan 1
TW - Taiwan 1
Totale 2.800
Città #
Ann Arbor 545
Singapore 133
Dublin 132
Milan 125
Frankfurt am Main 118
Chandler 86
New York 74
Fairfield 70
Wilmington 68
Woodbridge 62
Hong Kong 52
Santa Clara 52
Ashburn 39
Seattle 34
Houston 32
Jakarta 28
Shanghai 28
Princeton 24
Cambridge 20
Lissone 19
Monza 16
Helsinki 14
Romola 14
Rome 13
Lawrence 12
Altamura 11
Munich 11
Los Angeles 10
Beijing 9
Guangzhou 9
Bologna 8
Como 8
Dallas 8
Dong Ket 8
Jacksonville 8
San Diego 8
Turin 8
Dearborn 7
Nuremberg 7
Sesto San Giovanni 7
Boardman 6
Carate Brianza 6
Fremont 6
Lappeenranta 6
London 6
Andover 5
Tianjin 5
Assago 4
Bonndorf 4
Cinisello Balsamo 4
Desio 4
Falls Church 4
Genoa 4
Lisbon 4
Lodz 4
Olomouc 4
Oslo 4
Pune 4
Sacramento 4
Tehran 4
Toronto 4
Agrate Brianza 3
Ankara 3
Arese 3
Bergamo 3
Bogotá 3
Ceret 3
Chicago 3
Colorado Springs 3
Corbetta 3
Delhi 3
Kocaeli 3
Legnano 3
Lleida 3
Nanchang 3
Sacavém 3
Seriate 3
Usmate Velate 3
Aurora 2
Baku 2
Bari 2
Bhopal 2
Cesano Maderno 2
Cologne 2
Coventry 2
Dresden 2
Gorgonzola 2
Haikou 2
Hangzhou 2
Hounslow 2
Huizhou 2
Jiaxing 2
Jinan 2
Kragujevac 2
Latina 2
Manila 2
Marino 2
Marseille 2
Milton Keynes 2
Mumbai 2
Totale 2.128
Nome #
Chronic myeloid leukemia: Second-line drugs of choice 272
Integrated Genomic, Functional and Prognostic Characterization of Atypical Chronic Myeloid Leukemia (aCML) in a Cohort of 43 Patients 196
Integrated Genomic, Functional, and Prognostic Characterization of Atypical Chronic Myeloid Leukemia 194
Phase two study of crizotinib in patients with anaplastic lymphoma kinase (ALK) positive anaplastic large cell lymphoma relapsed/refractory to chemotherapy 193
Deferasirox in the management of iron-overload in patients with myelofibrosis: a multicentre study from the Rete Ematologica Lombarda (IRON-M study) 173
Clinical Benefit of Lenzilumab in Cases of Coronavirus Disease 2019 170
Long-term and low-dose of busulfan is a safe and effective second-line treatment in elderly patients with essential thrombocythemia resistant or intolerant to hydroxyurea 165
Treatment of Philadelphia-negative myeloproliferative neoplasms in accelerated/blastic phase with azacytidine. Clinical results and identification of prognostic factors 155
Evaluating the performance of large language models in haematopoietic stem cell transplantation decision-making 154
First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis 140
Transfusion of blood products derived from SARS-CoV-2+ donors to patients with hematological malignancies 134
Neurological symptoms in essential thrombocythemia: Impact of JAK2V617F mutation and response to therapy 118
Tyrosine Kinase Inhibitor discontinuation in Chronic Myeloid Leukemia: eligibility criteria and predictors of success 111
Idiopathic erythrocytosis: a germline disease? 108
Characterization of SARS-CoV-2 Mutational Signatures from 1.5+ Million Raw Sequencing Samples 93
Evolutionary signatures of human cancers revealed via genomic analysis of over 35,000 patients 90
Iron chelation therapy with deferasirox in the management of iron overload in primary myelofibrosis 83
Effects of blocking CD24 and CD47 'don't eat me' signals in combination with rituximab in mantle-cell lymphoma and chronic lymphocytic leukaemia 68
Humoral and cellular immune response in patients with hematological disorders after two doses of BNT162b2 mRNA COVID-19 vaccine: A single-center prospective observational study (NCT05074706) 68
Validation of a new NGS-based myeloid panel in acute myeloid leukemia: A single-center experience 67
A monocentric analysis of the long-term safety and efficacy of crizotinib in relapsed/refractory ALK+ lymphomas 62
Caution in using second generation tyrosine kinase inhibitor, especially for first line therapy of chronic myeloid leukemia 35
Hb Monza: A novel extensive HBB duplication with preserved α-β subunit interaction and unstable hemoglobin phenotype 25
Anaplastic Lymphoma Kinase (ALK) Inhibitors Enhance Phagocytosis Induced by CD47 Blockade in Sensitive and Resistant ALK-Driven Malignancies 18
Advances and Hurdles in CAR T Cell Immune Therapy for Solid Tumors 2
ALK inhibitors increase ALK expression and sensitize neuroblastoma cells to ALK.CAR-T cells 2
Post-Transplant Lymphoproliferative Disease (PTLD) after Allogeneic Hematopoietic Stem Cell Transplantation: Biology and Treatment Options 2
Totale 2.898
Categoria #
all - tutte 11.768
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.768


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202051 0 0 0 0 0 0 0 17 11 13 5 5
2020/2021663 37 17 66 57 58 75 58 60 69 47 58 61
2021/2022295 52 36 48 38 14 23 4 8 7 10 17 38
2022/2023421 37 117 37 27 24 62 29 8 35 12 26 7
2023/2024650 14 20 30 27 61 175 96 25 67 42 26 67
2024/2025689 56 141 88 76 119 88 113 8 0 0 0 0
Totale 2.898